Lilly Simplifies Chronic Disease Management with New Digital Platform: LillyDirect

What You Should Know:

Eli Lilly and Company (NYSE: LLY) announced today the launch of LillyDirect™, a comprehensive digital healthcare platform designed to empower patients living with obesity, migraine, and diabetes in the U.S. This innovative initiative aims to simplify chronic disease management by offering convenient resources, personalized support, and direct home delivery of select Lilly medications.

Key Features of LillyDirect

LillyDirect Pharmacy Solutions: This digital pharmacy platform simplifies access to select Lilly medications through third-party online fulfillment services. Patients can enjoy the convenience of home delivery and automatic application of Lilly’s affordability solutions and savings cards, if applicable.

Educational Resources: LillyDirect provides valuable information and support tailored to each disease state, empowering patients to make informed decisions and manage their health effectively.

Telehealth Access: Patients can connect with independent telehealth providers, complementing their existing care team or offering an alternative for specific needs.

Healthcare Provider Search Tool: For those seeking in-person care, LillyDirect offers an independent search tool to locate healthcare professionals near them.

“Digital solutions have become increasingly important in our daily lives, and healthcare is no exception,” remarked Frank Cunningham, group vice president, global value and access at Lilly. “LillyDirect is designed to provide patients with a seamless and convenient experience for managing their health and accessing their medications, allowing them to focus on living their lives.”